Merit Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Buy |
79,581
+20,548
| +35% | +$3.81M | 0.16% | 100 |
|
|
2025
Q1 | $12.4M | Buy |
59,033
+9,807
| +20% | +$2.05M | 0.19% | 92 |
|
|
2024
Q4 | $8.75M | Buy |
49,226
+1,375
| +3% | +$244K | 0.16% | 119 |
|
|
2024
Q3 | $9.45M | Buy |
47,851
+1,163
| +2% | +$230K | 0.21% | 82 |
|
|
2024
Q2 | $8.01M | Buy |
46,688
+2,399
| +5% | +$411K | 0.18% | 96 |
|
|
2024
Q1 | $7.25M | Buy |
44,289
+18,522
| +72% | +$3.03M | 0.17% | 101 |
|
|
2023
Q4 | $3.99M | Sell |
25,767
-14,814
| -37% | -$2.3M | 0.12% | 119 |
|
|
2023
Q3 | $6.05M | Buy |
40,581
+2,151
| +6% | +$321K | 0.2% | 80 |
|
|
2023
Q2 | $5.18M | Buy |
38,430
+7,149
| +23% | +$963K | 0.17% | 93 |
|
|
2023
Q1 | $4.99M | Sell |
31,281
-1,804
| -5% | -$288K | 0.18% | 86 |
|
|
2022
Q4 | $5.35M | Buy |
33,085
+1,634
| +5% | +$264K | 0.19% | 78 |
|
|
2022
Q3 | $4.22M | Sell |
31,451
-8,039
| -20% | -$1.08M | 0.18% | 74 |
|
|
2022
Q2 | $6.05M | Buy |
39,490
+25,753
| +187% | +$3.94M | 0.19% | 73 |
|
|
2022
Q1 | $2.23M | Buy |
13,737
+842
| +7% | +$137K | 0.13% | 96 |
|
|
2021
Q4 | $1.75M | Sell |
12,895
-217
| -2% | -$29.4K | 0.17% | 65 |
|
|
2021
Q3 | $1.41M | Buy |
13,112
+108
| +0.8% | +$11.6K | 0.15% | 74 |
|
|
2021
Q2 | $1.47M | Buy |
13,004
+40
| +0.3% | +$4.51K | 0.14% | 75 |
|
|
2021
Q1 | $1.4M | Buy |
12,964
+956
| +8% | +$103K | 0.15% | 71 |
|
|
2020
Q4 | $1.29M | Buy |
12,008
+2,001
| +20% | +$214K | 0.12% | 68 |
|
|
2020
Q3 | $876K | Buy |
10,007
+1,773
| +22% | +$155K | 0.08% | 96 |
|
|
2020
Q2 | $808K | Buy |
8,234
+1,247
| +18% | +$122K | 0.08% | 93 |
|
|
2020
Q1 | $532K | Buy |
6,987
+256
| +4% | +$19.5K | 0.06% | 118 |
|
|
2019
Q4 | $596K | Buy |
+6,731
| New | +$596K | 0.05% | 122 |
|